MENU

Can Solesence (SLSN) Stock Reach $1.00?

A.I.Advisor
published price charts
A.I.Advisor
Nov 10, 2026

Can Solesence (SLSN) Stock Reach $1.00?

Solesence, Inc. (SLSN), formerly Nanophase Technologies Corporation, is a Romeoville, Illinois-based developer and manufacturer of mineral-based skincare and sun-care products, including surface-engineered zinc oxide and titanium dioxide ingredients. As a NASDAQ-listed micro-cap with a market capitalization of roughly $63 million, the company occupies a small, specialized niche within the household and personal products industry.

Key Takeaways

  • The central target in this analysis is $1.00, roughly 11% above the most recent verified price near $0.90, based on a publicly discussed milestone rather than an analyst consensus.
  • This target was established using the fallback method: the stock lacks meaningful numeric analyst price targets, so the $1.00 level is derived from the NASDAQ $1.00 minimum bid price requirement and the psychological "dollar" threshold.
  • The required move from about $0.90 to $1.00 is a modest one, though micro-cap volatility means even small dollar moves can be percentage-large.
  • Coverage is thin and cautious; published ratings are qualitative "Sell" or "Underperform" calls, with no credible individual price targets to aggregate.
  • Supporting factors include the compliance significance of $1.00, a roughly $55 million revenue base, and growing consumer demand for mineral and "clean" skincare.
  • The biggest risks are continued net losses, a thin cash position, an elevated debt-to-equity ratio, and the company's disclosed NASDAQ listing-deficiency status.
  • For more context, explore the ticker's Major News, Today's Price Move, Forecast, and Earnings pages.
  • Readers interested in AI-driven market monitoring can also explore Trending AI Robots.

Analyst Coverage and How the Target Was Established

Solesence does not have a meaningful set of credible, current numeric analyst price targets to aggregate. MarketBeat reports a consensus price target of "N/A" with a single "Sell" rating on file, while Zacks Investment Research initiated coverage with an Underperform recommendation and Weiss Ratings has maintained a "Sell"-type qualitative rating. One third-party feed showing an extremely high "average target" is clearly a data-entry artifact and is excluded from this analysis.

Because no usable analyst targets exist, the central target is not an analyst consensus. Instead, it reflects a publicly discussed, verifiable milestone: the $1.00 level. NASDAQ generally requires listed companies to maintain a minimum closing bid price of $1.00, and Fidelity's quote page flags SLSN as having failed to meet NASDAQ continued listing requirements. Regaining and holding the $1.00 mark therefore carries concrete compliance significance beyond its role as a psychological round-number level.

Current Market Position and Path Toward the Target

The most recent verified price for SLSN is approximately $0.90, with the stock trading in a 52-week range of roughly $0.61 to $3.17. Reaching $1.00 requires an upside of about 11%, a modest move by percentage standards but one that still demands sustained buying in a thinly traded micro-cap.

The path toward $1.00 likely runs through improved quarterly results and clearer progress on listing compliance. The company reports trailing-twelve-month revenue of about $55.4 million against a net loss of roughly $2.9 million, with diluted EPS (earnings per share) of approximately -$0.04. A return to profitability, or at least a narrowing loss with revenue stabilization, would give investors a firmer fundamental basis to support the shares.

What Could Support a Move Toward the Target

The strongest support for a move to $1.00 is its dual role as a listing-compliance threshold and a psychological anchor. If management communicates a credible plan to regain NASDAQ compliance, investor attention could concentrate on that milestone. Solesence's positioning in mineral-based, "clean" skincare also aligns with durable consumer trends, and its proprietary Active Stress Defense technology provides differentiation in the sun-care and personal-care markets. A revenue base above $50 million shows the company is not a pre-revenue development-stage business, even if profitability remains elusive.

What Could Prevent the Target From Being Reached

Several factors could keep the shares below $1.00. The company has posted net losses and carries negative EPS, with a thin cash balance of roughly $1.05 million and a debt-to-equity ratio near 172%, leaving limited financial cushion. The disclosed NASDAQ deficiency raises the risk of delisting proceedings if the bid price does not recover. As a micro-cap with low average volume, the stock is also vulnerable to sharp swings on modest trading activity, and the caution expressed in available ratings suggests sentiment remains skeptical.

Technical Levels and Market Structure

The $1.00 mark sits just above the current price and represents both a psychological level and a compliance threshold, making it a natural focal point. Below it, recent trading has found support in the $0.85–$0.86 area. The 52-week high near $3.17, reached in late 2025, underscores how far the stock has fallen, while the 52-week low near $0.61, set in mid-2026, marks the downside extreme. A sustained close above $1.00 would be a meaningful structural change, while repeated failure at that level could reinforce it as resistance.

Time Horizon and What Investors Should Monitor

Because the $1.00 target is tied to a listing-compliance milestone rather than a formal analyst research horizon, no single 12-month assumption applies. Investors should watch the company's next earnings release, scheduled for November 12, 2026, along with any statements from management about NASDAQ compliance, revenue trends, margin progress, and cash position. Corporate announcements regarding listing status and any reverse-stock-split considerations, which are common compliance tools, would be especially relevant to the $1.00 objective.

AI Daily Buy/Sell Signals

Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. For a volatile micro-cap like Solesence, such tools can help traders spot changing trends and monitor positions more efficiently without manually reviewing every chart. Traders seeking to identify opportunities and react to momentum shifts can use these signals as part of a broader research process.

Final Assessment

The question of whether Solesence (SLSN) can reach $1.00 is less about analyst conviction — there is effectively none to measure — and more about a compliance-driven, psychological milestone. At roughly $0.90, the required move is a modest 11%, but it must be achieved against continued losses, a thin cash position, high leverage, and a disclosed listing deficiency. The strongest supports are the concrete significance of $1.00 for NASDAQ compliance and the company's alignment with durable clean-skincare demand. The principal obstacles are financial fragility and weak sentiment. Investors should monitor earnings, listing-status communications, and whether the stock can hold above the $0.85 support zone, while recognizing that no outcome is guaranteed.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
Interact to see
Advertisement

SLSN and Stocks

Correlation & Price change

A.I.dvisor tells us that SLSN and NWL have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SLSN and NWL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLSN
1D Price
Change %
SLSN100%
-9.76%
NWL - SLSN
14%
Poorly correlated
-4.59%
NUS - SLSN
11%
Poorly correlated
-2.58%
HELE - SLSN
10%
Poorly correlated
-5.29%
CNEY - SLSN
10%
Poorly correlated
-13.41%
HNST - SLSN
9%
Poorly correlated
-6.08%
More

Groups containing SLSN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLSN
1D Price
Change %
SLSN100%
-9.76%
Household/Personal Care
industry (30 stocks)
-1%
Poorly correlated
-4.05%
Can Solesence (SLSN) Stock Reach $1.00?